The company’s future digital healthcare plans include expansion into therapeutic areas such as pain, CNS, allergy, oncology, diabetes and more
Continuing its journey into digital health, Aptar Pharma has named Nordic Semiconductor a key supplier for its digital solutions portfolio.
The semiconductor company will supply its Bluetooth low energy System-on-Chip (LE SoC) for applications including Aptar’s Connected Device for metered dose inhalers (MDIs), which is used with pressurised metered dose inhalers to treat asthma & COPD.
The Bluetooth LE SoC enables the smart Connected Device for MDIs to communicate all of the information generated back to the patient’s smartphone, including date and time stamp, co-ordination information, inspiratory flow and more. Such features provide the patient and healthcare provider with insights into patient training, onboarding and adherence to their medication, as well as the potential for diagnostics data.
The chip is designed to provide the necessary level of performance at a competitive cost, ensuring Aptar has an offering that meets the needs of an extremely cost-sensitive market.
Thomas Søderholm, Director Business Development, Nordic Semiconductor ASA said: “We are thrilled Aptar Pharma has chosen Nordic Semiconductor as a key supplier for its connected drug delivery platform. Healthcare is something that is near and dear to us, and as a leader in the connectivity space, we strive to help connect the patients of tomorrow. We are proud to be working with an innovative and forward-thinking company like Aptar Pharma to improve people’s lives.”
“We are very pleased to partner with Nordic Semiconductor to support Aptar Pharma’s continued journey into digital health,” said Sai Shankar, VP, Global Digital Healthcare Systems, Aptar Pharma. “Partnering with Nordic helps ensure that Aptar can react to the changing demands of the marketplace, ensuring that shared insights lead to our ever-evolving offering.”